Combining nilotinib and imatinib improves the outcome of imatinib-resistant blast phase CML.
2012
Imatinib resistance is an important hurdle in the treatment of chronic myeloid leukemia (CML), and CML patients with this drug resistance are often given a dismal prognosis. In this case report, an im
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
8
References
4
Citations
NaN
KQI